Rare diseases
Investigational molecules
Locations
453 conditions with trials, the busiest first
1 389 trials across Europe, recruiting first
Study of rimegepant for preventing chronic migraine in adolescents aged 12 to 17 years
CzechiaStudy of fampridine treatment for patients with spinocerebellar ataxia SCA27B caused by FGF14 gene mutation
FranceStudy of Descartes-08 compared to placebo in adults with generalized myasthenia gravis
ItalyStudy of perineural incobotulinumtoxinA treatment for patients with Complex Regional Pain Syndrome type I or II affecting one side of the body
DenmarkStudy of zorevunersen to reduce seizures in patients with Dravet syndrome
FranceStudy of drug interactions between leriglitazone, gemfibrozil, itraconazole, and carbamazepine and food effects in healthy male volunteers for adrenoleukodystrophy treatment
PolandStudy comparing subcutaneous versus intravenous ublituximab in patients with relapsing multiple sclerosis
BulgariaStudy of VS-01 with different treatment times compared to standard care alone in patients with overt hepatic encephalopathy and liver cirrhosis complications
BelgiumStudy of ALKS 2680 to treat excessive daytime sleepiness in people with idiopathic hypersomnia
BelgiumComparing Skin Adhesiveness of a New Rotigotine 12 mg/24 h Transdermal Patch Versus Standard Treatment in Patients with Parkinson's Disease
GermanyStudy comparing empasiprubart versus intravenous immunoglobulin for treating adults with multifocal motor neuropathy
AustriaStudy on the Effects of Cilostazol on Headaches in Men and Women with Migraine Without Aura
DenmarkThe therapies tested most often in Nervous system disorders trials.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
